Pharmacist Review of Chronic Inhaler Therapy Appropriateness for Hospitalized Patients with COPD or Asthma.
Tate D ParrottMatthew D WallaceKristina M NiehoffSarah H EbleLauren BlumenfeldCarla M SevinNeesha N ChomaYue GaoLeena ChoiChristopher J LindsellAutumn D ZuckermanPublished in: Journal of the American College of Clinical Pharmacy : JACCP (2023)
A pharmacist-led review of chronic inhaler therapy for patients admitted to the hospital identified the need for a change in therapy based on financial or clinical guidelines in over half of the patients reviewed. Interventions to increase the appropriateness of prescribed inhalers are needed to reduce disease progression and disease exacerbation.
Keyphrases
- chronic obstructive pulmonary disease
- end stage renal disease
- lung function
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- stem cells
- patient reported outcomes
- cystic fibrosis
- mesenchymal stem cells
- intensive care unit
- young adults
- allergic rhinitis
- bone marrow
- adverse drug
- extracorporeal membrane oxygenation
- patient reported
- smoking cessation